Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.75 EUR
−6.16 M EUR
23.13 M EUR
10.85 M
About PHILOGEN
Sector
CEO
Dario Neri
Headquarters
Siena
Website
Founded
1996
ISIN
IT0005373789
FIGI
BBG000QL1KW3
Philogen SpA engages in the engineering and clinical development of lead products capable of targeting angiogenesis. Its products include Nidlegy, Fibromun, Darleukin, Dodekin, Onco IX, Tripokin, OncoFAP, and Dekavil. The company was founded by Dario Neri, Duccio Neri, and Giovanni Neri in 1996 and is headquartered in Siena, Italy.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of PHIL is 19.95 EUR — it has decreased by −0.50% in the past 24 hours. Watch PHILOGEN stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on MIL exchange PHILOGEN stocks are traded under the ticker PHIL.
PHIL stock has risen by 0.25% compared to the previous week, the month change is a −0.50% fall, over the last year PHILOGEN has showed a 10.83% increase.
We've gathered analysts' opinions on PHILOGEN future price: according to them, PHIL price has a max estimate of 25.00 EUR and a min estimate of 23.00 EUR. Watch PHIL chart and read a more detailed PHILOGEN stock forecast: see what analysts think of PHILOGEN and suggest that you do with its stocks.
PHIL reached its all-time high on Aug 20, 2024 with the price of 21.90 EUR, and its all-time low was 12.60 EUR and was reached on Jul 20, 2021. View more price dynamics on PHIL chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
PHIL stock is 1.26% volatile and has beta coefficient of −0.05. Track PHILOGEN stock price on the chart and check out the list of the most volatile stocks — is PHILOGEN there?
Yes, you can track PHILOGEN financials in yearly and quarterly reports right on TradingView.
PHILOGEN is going to release the next earnings report on Apr 1, 2025. Keep track of upcoming events with our Earnings Calendar.
PHIL earnings for the last half-year are −0.39 EUR per share, whereas the estimation was −0.32 EUR, resulting in a −21.88% surprise. The estimated earnings for the next half-year are 6.15 EUR per share. See more details about PHILOGEN earnings.
PHILOGEN revenue for the last half-year amounts to 1.71 M EUR, despite the estimated figure of 3.50 M EUR. In the next half-year revenue is expected to reach 302.80 M EUR.
PHIL net income for the last half-year is −15.52 M EUR, while the previous report showed −13.83 M EUR of net income which accounts for −12.17% change. Track more PHILOGEN financial stats to get the full picture.
No, PHIL doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 21, 2024, the company has 165.00 employees. See our rating of the largest employees — is PHILOGEN on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. PHILOGEN EBITDA is −31.11 M EUR, and current EBITDA margin is −31.09%. See more stats in PHILOGEN financial statements.
Like other stocks, PHIL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PHILOGEN stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So PHILOGEN technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating PHILOGEN stock shows the buy signal. See more of PHILOGEN technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.